Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Quetiapine and Paediatric Psychiatrica: Evidence or Diffidence?
1
x
$
30.00
The Role of Religiosity and Guilt in Symptomatology and Outcome of Obsessive Compulsive Disorder
1
x
$
30.00
View Cart
Checkout
Home
Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
$
30.00
Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 1 Articles
Tags:
adverse-events
,
antipsychotic
,
cytochrome-p-450
,
drug-interactions
,
hepatic
,
md-deanna-l-kelly
,
psychotropic
,
robert-r-conley
Description
Description
Robert R. Conley, MD
DRUG DISPOSITION & PHARMACOKINETICS
Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP
PB-40-1-07-Conley
Related products
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 48 No. 3, 2018 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Jennifer L. Donovan, PhD: A Primer on Caffeine Pharmacology and Its Drug Interactions in Clinical Psychopharmacology
$
30.00
Add to cart
Details
Michael T. Compton, MD: Antipsychotic-Induced Hyperprolactinemia and Sexual Dysfunction
$
30.00
Add to cart
Details
Page load link
Go to Top